SB121 amends the Medical Malpractice Act’s provisions governing New Mexico’s Patient’s Compensation Fund, which is the state fund used to pay certain malpractice judgments and settlements above the amount covered by a health care provider’s own insurance. The bill’s central change is to grant immunity from liability to the third-party administrator that administers the fund, aligning that administrator’s protection with the immunity already afforded to the superintendent when acting within the scope of the Act.
The bill also updates and restates several operational provisions for the fund, including surcharge collection, actuarial review, confidentiality of provider financial and claims data, proration if the fund is exhausted, and the documentation required before the superintendent may issue payment from the fund. It preserves the existing structure in which health care providers pay surcharges into the fund through their insurers and claims are paid according to court-ordered schedules, while continuing the statutory framework for fund solvency and administration.
Impact
SB121 would amend Section 41-5-25 NMSA 1978 to expressly extend liability immunity to the fund’s third-party administrator and to reinforce the administrator’s role in managing the Patient’s Compensation Fund. It would not create a new fund or fundamentally alter malpractice coverage, but it would affect the legal exposure of the contractor administering the fund and clarify the handling of confidential claims and financial information used for actuarial and surcharge-setting purposes. Health care providers, insurers, hospitals, outpatient facilities, and malpractice claimants would continue to be governed by the existing Patient’s Compensation Fund system, with the bill primarily affecting administration and liability protections.
Sentiment
The bill appears generally technical and administrative in nature, with no recorded committee debate or votes in the provided materials. Based on the text, the measure seems aimed at stabilizing and protecting the operation of the Patient’s Compensation Fund rather than changing substantive malpractice rights, which suggests a likely pragmatic or supportive posture from sponsors and stakeholders focused on fund administration. No opposing sentiment is documented in the available record.
Contention
The main potential point of contention is the expansion of immunity to the third-party administrator, which may concern parties who want clearer accountability for fund administration or who worry about limiting remedies for administrative errors. Another possible issue is the continued use and confidentiality of provider financial and claims data for actuarial purposes, especially because the bill restricts public records access to some of that information. Beyond those issues, the bill’s provisions on surcharges, solvency, and payment proration could matter to hospitals, outpatient facilities, insurers, and malpractice claimants, but no direct opposition is shown in the available history.